Beijing (AFP) March 23, 2021
China's drug authority has approved for clinical trials an inhaled Covid-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a filing on Tuesday. The move comes after the National Medical Products Administration gave another CanSino vaccine conditional approval last month, allowing it for public use. China currently has five coronavirus vaccines that have been
China approves inhaled CanSino vaccine for clinical trials
Terra Daily
0 shares
2 views
You might like
Related news coverage
China aims to vaccinate 70-80% of population by mid-2022
BEIJING (AP) — China is aiming to vaccinate 70-80% of its population by mid-2022, the head of the country's Center for Disease..
SeattlePI.com
Mexico to rely heavily on Chinese vaccines
MEXICO CITY (AP) — Mexico announced a huge bet on Chinese vaccines Tuesday, without making public any information about their..
SeattlePI.com